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Negative regulators of signal transduction cascades play
critical roles in controlling different aspects of normal
embryonic development. Sprouty2 negatively regulates
FGF signaling and Receptor Tyrosine Kinases (RTK) and
is important in differentiation, cell migration and prolifera-
tion. In vertebrate embryos, Sprouty2 is expressed in pre-
segmented mesoderm and in forming somites. Expression
is maintained in the myotome until late stages of somite
differentiation. However, its role and mode of action dur-
ing somite myogenesis is still unclear. In the current
study, we analysed chick Sprouty2 expression and showed
that it overlaps with that of Myogenic Regulatory Factors
(MRF) MyoD and Mgn. Targeted mis-expression of Spro-
uty2 led to inhibition of myogenesis, whilst its C-terminal
domain interference led to an increased number of myo-
genic cells by stimulating cell proliferation. Our results
show that Sprouty2 plays crucial role in regulating chick
myogenesis by fine tuning of FGF signaling through a
negative feedback loop.
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